Moreover, organoid models sourced from HCC patients have illustrated that metformin can reactivate peroxisome proliferator-activated receptor-gamma coactivator-1α (PPARGC1A) expression and augment ferroptosis, underscoring its relevance in the pathogenesis of HCC and potential therapeutic strategies [58]. This evidence concerns the gene PPARGC1A and hepatocellular carcinoma.